力生制药：为投资者创造可持续的价值回报

Core Viewpoint - The company aims to enhance research and development alongside industrial synergy, while also advancing ESG management and digitalization to provide better quality medicines for patients and sustainable value returns for investors [1] Group 1 - The company will continue to deepen research and development efforts [1] - The company is committed to advancing ESG (Environmental, Social, and Governance) management [1] - The company focuses on digitalization initiatives [1] Group 2 - The company is dedicated to providing higher quality medicines for patients [1] - The company aims to create sustainable value returns for investors [1]